ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full-service contract research organization, also known as the #Antibiotic Powerhouse as pronounced by one of many of its infectious disease customers, announced today that they will, of course, be attending the upcoming ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) in San Diego, CA.
PSI will be represented at ICAAC at Booth #829 beginning Friday, September 18th through Sunday, September 20th at the San Diego Convention Center.
PSI’s therapeutically aligned infectious diseases team that supports ID clinical trials at PSI will be in attendance. The team will include antimicrobial clinical trial experts and ID specialists from Medical Affairs, Project Management, as well as representatives of senior management.
PSI continues to impact development of new antibiotics and speed up arrival of novel drugs to market through the successful management and on-time delivery of most complex global trials in the areas of CAP/HAP/VAP, cUTI, IAI, skin infections, sepsis, bacteremia and other infections.
About PSI CRO AG: PSI is a Swiss-based privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (near Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com
